1. Home
  2. LMAT vs NNNN Comparison

LMAT vs NNNN Comparison

Compare LMAT & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LMAT
  • NNNN
  • Stock Information
  • Founded
  • LMAT 1983
  • NNNN 2021
  • Country
  • LMAT United States
  • NNNN Germany
  • Employees
  • LMAT N/A
  • NNNN N/A
  • Industry
  • LMAT Medical/Dental Instruments
  • NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • LMAT Health Care
  • NNNN Health Care
  • Exchange
  • LMAT Nasdaq
  • NNNN Nasdaq
  • Market Cap
  • LMAT 1.9B
  • NNNN 2.2B
  • IPO Year
  • LMAT 2006
  • NNNN 2025
  • Fundamental
  • Price
  • LMAT $95.18
  • NNNN $44.60
  • Analyst Decision
  • LMAT Buy
  • NNNN
  • Analyst Count
  • LMAT 6
  • NNNN 0
  • Target Price
  • LMAT $99.67
  • NNNN N/A
  • AVG Volume (30 Days)
  • LMAT 222.0K
  • NNNN 92.9K
  • Earning Date
  • LMAT 10-30-2025
  • NNNN 01-01-0001
  • Dividend Yield
  • LMAT 0.84%
  • NNNN N/A
  • EPS Growth
  • LMAT 22.69
  • NNNN N/A
  • EPS
  • LMAT 2.05
  • NNNN 0.06
  • Revenue
  • LMAT $234,639,000.00
  • NNNN $8,185,146.00
  • Revenue This Year
  • LMAT $16.32
  • NNNN N/A
  • Revenue Next Year
  • LMAT $8.62
  • NNNN N/A
  • P/E Ratio
  • LMAT $46.52
  • NNNN $833.12
  • Revenue Growth
  • LMAT 14.11
  • NNNN 21.95
  • 52 Week Low
  • LMAT $71.42
  • NNNN $5.18
  • 52 Week High
  • LMAT $109.58
  • NNNN $55.65
  • Technical
  • Relative Strength Index (RSI)
  • LMAT 62.44
  • NNNN N/A
  • Support Level
  • LMAT $94.06
  • NNNN N/A
  • Resistance Level
  • LMAT $100.97
  • NNNN N/A
  • Average True Range (ATR)
  • LMAT 2.54
  • NNNN 0.00
  • MACD
  • LMAT -0.27
  • NNNN 0.00
  • Stochastic Oscillator
  • LMAT 63.40
  • NNNN 0.00

About LMAT LeMaitre Vascular Inc.

LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

Share on Social Networks: